Some Factors Influencing Metabolism and Distribution of Fibrinogen in Man and Rabbits

Summary

To shed some light on the homeostatic regulation of plasma fibrinogen, metabolic studies were made in healthy females, and in normal, thyroidectomized, and thyroxine-treated rabbits. In females, compared with normal males, plasma fibrinogen concentration, plasma and interstitial fibrinogen decreased consequent to an increased fractional catabolic rate and a normal fibrinogen synthesis rate. The interstitial/plasma fibrinogen ratio remained unchanged. In normal rabbits, with increasing body weight fractional catabolic rate and catabolic rate decreased, while fibrinogen concentration and plasma fibrinogen remained constant owing to a simultaneous decrease in fibrinogen synthesis. In addition, fractional transcapillary transfer rate and transcapillary flux also decreased resulting in a shrinkage of interstitial fibrinogen. Thyroidectomy and thyroxine-injection markedly altered fibrinogen metabolism: thyroid hormone accelerated fibrinogen catabolism but also stimulated synthesis. The net result was an increase in plasma fibrinogen and fibrinogen concentration. The interstitial/plasma fibrinogen ratio decreased in thyroxine-treated, and increased in thyroidectomized animals. This study defines the variations of the fibrinogen system parameters in these physiologic and pathologic conditions, and illustrates some patterns of alterations in fibrinogen metabolism.

^* Present address: Department of Medicine, Veterans Administration West Side Hospital and University of Illinois at the Medical Center, Chicago, Illinois, U.S.A.

• References

• 1 Altman P. L, Dittmer D. S. (eds.) Metabolism (Biology Handbook), Federation of American Societies of Experimental Biology. Bethesda, Maryland: 1968
• 2 Atencio A. C, Reeve E. B. Studies on the metabolism and distribution of fibrinogen in young and old rabbits. II. Results. Journal of Laboratory and Clinical Medicine 1965; 66: 20
• 3 Atencio A. C, Bailey H. R, Reeve E. B. Studies on the metabolism and distribution of fibrinogen in young and older rabbits. I. Methods and models. Journal of Laboratory and Clinical Medicine 1965; a 66: 1
• 4 Atencio A. C, Burdick D. C, Reeve E. B. An accurate isotope dilution method for measuring plasma fibrinogen. Journal of Laboratory and Clinical Medicine 1965; b 66: 137
• 5 Atencio A. C, Joiner K, Reeve E. B. Experimental and control systems studies of plasma fibrinogen regulation in rabbits. American Journal of Physiology 1969; 216: 764
• 6 Brody S. Bioenergetics and Growth. Reinhold Publisher; New York.: 1945
• 7 Chen Y. Studies on the homeostatic regulation of plasma fibrinogen. Ph. D. Thesis. University of Colorado.; 1970
• 8 Chen Y, Briese F. W, Reeve E. B. Relation of fibrinogen secretion (synthesis) to ACTH dose. American Journal of Physiology 1974; 227: 932
• 9 Dewey W. C. Vascular-extravascular exchange of¹³¹I plasma proteins in the rat. American Journal of Physiology 1959; 197: 423
• 10 Draper N. R, Smith H. Applied Regression Analysis. John Wiley and Sons, Inc.; New York.: 1966
• 11 Fletcher A. P, Alkjersig N, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) state. I. Significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. Journal of Clinical Investigation 1962; 41: 896
• 12 Hegsted D. M. Proteins. In Beaton G. H. (ed.) Nutrition. Volume I. Academic Press; New York: Chapter 3. 1964
• 13 Kowalski E. Fibrinogen derivatives and their biologic activity. Seminars in Hematology 1968; 5: 45
• 14 Marquardt P. W. An algorithm for least squares estimation of non-linear parameters. Journal of Society of Industrial and Applied Mathematics 1963; 2: 431
• 15 Mcfarlane A. S. In vivo behavior of ¹³¹I fibrinogen. Journal of Clinical Investigation 1963; 42: 346
• 16 Reeve E. B, Chen A. Y. Regulation of interstitial albumin. In Rothschild M. A, Waldmann T. (eds.) Plasma Protein Metabolism. Academic Press; New York: 1970. p. 89
• 17 Schultze W. L. Protein metabolism and requirement in old age. In Old Age in Modern World E. and S. Livingston; London: 1955. p. 122
• 18 Seegers W. H. (ed.) Blood Clotting Enzymology. Academic Press; New York.: 1967
• 19 Sherry S. Current status of fibrinogen and fibrin degradation products. In Owren P. A. (ed.) Fibrinogen: Structure, Metabolic and Pathophysiologic Aspects. (Symposium) Stuttgart; Schattauer: 1970. p. 169
• 20 Snedecor G. W, Cochran W. G. Statistical Methods. The Iowa State University Press; Iowa City.: 1967
• 21 Stachurska J, Latallo Z, Kopec M. Inhibition of platelet aggregation by dialysable fibrinogen degradation products (FDP). Thrombosis et Diathesis Haemorrhagica 1970; 23: 91
• 22 Takeda Y. Studies of the metabolism and distribution of fibrinogen in healthy men with autologous ¹²⁵I-labeled fibrinogen. Journal of Clinical Investigation 1966; 45: 103